What's new

China Science & Technology Forum

 
.
.
China achieves breakthroughs in self-developed no liquid helium dilution refrigerators to solve bottleneck problem in quantum computing
By Global Times
Published: Jul 13, 2021 11:25 AM

Photo: stdaily.com

Photo: stdaily.com

China achieves breakthroughs in self-developed no liquid helium dilution refrigerator, targeting the bottleneck problem in quantum computing, as the technology will guard China’s study and development of quantum computing with a steady cryogenic guarantee, according to an announcement from the Institute of Physics, Chinese Academy of Sciences in June.

The complete self-developed prototype of no liquid helium dilution refrigerator by the Institute of Physics has achieved a long-term stable and continuous operation of 10.9 mK (-273.14 degrees) on June 24, marking a significant breakthrough in China’s development of high-end cryogenic machines.

China currently completely relies on imports of helium dilution refrigerators, but the country has identified developing a domestic production capacity as a key priority, science media stdaily.com reported on Tuesday, citing Ji Zhongqing, a researcher from the Institute of Physics.

Helium dilution refrigerators are an irreplaceable element for the research and development of quantum computing, providing an extreme cryogenic environment for quantum computers to function normally, according to stdaily.com.

No liquid helium dilution refrigerators are able to achieve an extreme temperature of just 0.01 degree above the absolute zero without the aid of liquid helium, which are also the dilution refrigerators with the lowest temperature that are commercially available on the market, according to media reports.

The newly developed prototype of no liquid helium dilution refrigerator will solve the bottleneck problem in quantum computing, said Ji, adding that mastering the core technology of dilution refrigeration indicates that China has the ability to provide extremely low temperature conditions for cutting-edge research including quantum computing.
 
.
Researchers develop transparent power-generating windows
Source: Xinhua| 2021-07-15 20:48:56|Editor: huaxia

BEIJING, July 15 (Xinhua) -- Researchers from China, Germany and Britain have developed transparent power-generating windows to convert sunlight into electricity, according to a research article published in the journal Advanced Energy Materials.

Transparent photovoltaics have shown great potential, but increased transparency comes at the expense of reduced power-conversion efficiency.

The researchers developed the window by overcoming this limitation by combining solar-thermal-electric conversion with the wavelength-selective absorption of the material used.

The wavelength-selective film facilitates up to 88 percent of visible-light transmittance and outstanding ultraviolet and infrared absorbance, thereby converting absorbed light into heat without sacrificing transparency, according to the researchers.

A prototype that couples the film with thermoelectric power generation modules produces an extraordinary output of four voltages within an area of 0.01 square meters exposed to sunshine.

This technology can operate under ambient temperatures with high reliability and has great application prospects in transparent on-site power generation, thus allowing it to provide thermal comfort for building occupants. It could also complement rooftop solar panels and side windows of trains or automobiles.
 
.
来自 微博 weibo.com​
已编辑​
#人造万用血即将进入临床研究阶段#】记者19日从西北大学国家微检测工程技术研究中心获悉,由该中心和西安血氧生物技术有限公司血氧液研发团队历时20年研发的“人造万用血”已完成大鼠、犬和猴等全部动物实验,并通过国家权威新药安全性评价机构的评估:无临床意义的副反应,支持进入I期临床研究。(科技日报记者 史俊斌)​
Science and Technology Daily
7-19 19:05 from Weibo

[Universal artificial blood is about to enter the clinical trial stage]

The reporter learned from National Engineering Research Center for Micro-inspection, Northwest University on the 19th July that the center together with HBOCs R&D Team of Xi’an Blood Oxygen Biotechnology Co., Ltd. has completed all animal experiments in rats, dogs and monkeys for the "universal artificial blood" that they had researched for 20 years. Evaluation passed by the national authoritative new drug safety evaluation agency: No side effects with clinical significance support the entry into phase I clinical trial.
(Science and Technology Daily reporter Shi Junbin)

1626706619292.png

1626706744059.png
 
. .
 
.
The world’s first 14-valent HPV vaccine designed by Beijing enterprise enters clinical trials
By Global TimesPublished: Jul 22, 2021 03:48 PM

Women wait in line to receive HPV vaccines at a hospital in Xi'an, capital of Northwest China's Shaanxi Province in December 2017. Photo: VCG
Women wait in line to receive HPV vaccines at a hospital in Xi'an, capital of Northwest China's Shaanxi Province in December 2017. Photo: VCG

SinoCellTech, a Beijing-based biotech company, has rolled out the world's first 14-valent human papillomavirus (HPV) vaccine which has entered clinical trials, media reported on Thursday.

The 14-valent HPV vaccine developed by SinoCellTech covers all 12 high-risk cancerogenic HPV types and two major types of HPV causing condyloma acuminatum, the Beijing Daily reported on Thursday, emphasizing that the 14-valent vaccine has increased the protection of five virus subtypes compared with the imported 9-valent HPV vaccine and will be used to prevent diseases caused by HPV infection such as cervical cancer.

"According to the current trial data, the 14-valent HPV vaccine has the ability to increase the protection rate of cervical cancer prevention from 90 percent from the 9-valent HPV vaccine to 96 percent," per media reports, citing Tang Liming, Sino's vice president.

China's first domestically produced vaccine against the HPV has been available by appointment since May, 2020, making China the third country in the world to achieve an independent HPV vaccine supply after the US and the UK.
 
.

😳

This Fabric can be used by Special Forces & Frontline Troops to fool enemy Infrared night vision system
 
. . .
. .
Last edited:
. .

Pakistan Affairs Latest Posts

Back
Top Bottom